Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$737M |
| 2 |
American Tower
AMT
|
+$687M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$554M |
| 4 |
Abbott
ABT
|
+$553M |
| 5 |
SLB Ltd
SLB
|
+$449M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$1.06B |
| 2 |
Netflix
NFLX
|
+$816M |
| 3 |
Match Group
MTCH
|
+$678M |
| 4 |
NVIDIA
NVDA
|
+$611M |
| 5 |
Intuitive Surgical
ISRG
|
+$530M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.17% |
| 2 | Consumer Discretionary | 21.87% |
| 3 | Healthcare | 15.92% |
| 4 | Financials | 9.87% |
| 5 | Communication Services | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Gen Digital
GEN
$16.4B
| – | – |
-88,680
| Closed | -$2.35M |
|
652
Hyatt Hotels
H
$16.4B
| – | – |
-18,422
| Closed | -$1.76M |
|
653
Halozyme
HALO
$9.79B
| – | – |
-29,658
| Closed | -$1.18M |
|
654
HP
HPQ
$24.9B
| – | – |
-63,963
| Closed | -$2.32M |
|
655
Herc Holdings
HRI
$5.02B
| – | – |
-6,598
| Closed | -$1.1M |
|
656
International Bancshares
IBOC
$4.76B
| – | – |
-43,597
| Closed | -$1.84M |
|
657
KB Home
KBH
$3.37B
| – | – |
-14,748
| Closed | -$478K |
|
658
KLA
KLAC
$239B
| – | – |
-20,890
| Closed | -$765K |
|
659
Kennametal
KMT
$2.59B
| – | – |
-246,057
| Closed | -$7.04M |
|
660
Knowles
KN
$3.13B
| – | – |
-43,732
| Closed | -$942K |
|
661
Krystal Biotech
KRYS
$10.1B
| – | – |
-68,309
| Closed | -$4.54M |
|
662
nLIGHT
LASR
$3.88B
| – | – |
-959,866
| Closed | -$16.6M |
|
663
CS Disco
LAW
$250M
| – | – |
-12,932
| Closed | -$439K |
|
664
Lattice Semiconductor
LSCC
$17.6B
| – | – |
-36,536
| Closed | -$2.23M |
|
665
Macy's
M
$6.53B
| – | – |
-52,204
| Closed | -$1.27M |
|
666
McKesson
MCK
$100B
| – | – |
-5,989
| Closed | -$1.83M |
|
667
Methode Electronics
MEI
$496M
| – | – |
-26,041
| Closed | -$1.13M |
|
668
Moderna
MRNA
$21.8B
| – | – |
-17,579
| Closed | -$3.03M |
|
669
Mettler-Toledo International
MTD
$28.6B
| – | – |
-267
| Closed | -$367K |
|
670
New Jersey Resources
NJR
$5.84B
| – | – |
-19,557
| Closed | -$897K |
|
671
Norfolk Southern
NSC
$75.4B
| – | – |
-26,924
| Closed | -$7.68M |
|
672
Intellia Therapeutics
NTLA
$1.49B
| – | – |
-310,036
| Closed | -$22.5M |
|
673
Natera
NTRA
$38.3B
| – | – |
-304,768
| Closed | -$12.4M |
|
|
NVMI
674
Nova
NVMI
$12.4B
| – | – |
-3,601
| Closed | -$392K |
|
675
Nexstar Media Group
NXST
$5.82B
| – | – |
-4,153
| Closed | -$783K |
|
Similar funds
Jennison Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Jennison Associates held 720 positions worth $100B, down 26% from $136B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Jennison Associates withdrew a net $3.7B in Q2 2022, closing 106 positions and reducing 265 holdings. Its most notable exit was Okta, an estimated $272M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in KBR worth $40.4M.
- Jennison Associates's largest Q2 2022 buy was KBR: 834,334 shares worth $40.4M.
- Jennison Associates added most to Eli Lilly in Q2 2022, an estimated $737M increase.
- Jennison Associates's biggest Q2 2022 reduction was Shopify, cutting an estimated $1.06B.
- Jennison Associates fully exited Okta in Q2 2022, selling an estimated $272M.
- Jennison Associates's ten largest holdings make up 41% of its $100B portfolio in Q2 2022.
- Jennison Associates opened 95 new positions and closed 106 in Q2 2022.
- Jennison Associates's portfolio value fell 26% quarter-over-quarter to $100B.
Based on Jennison Associates's 13F filing for Q2 2022, filed 2 Aug 2022.